Panbela Therapeutics Valore dell'impresa
Cos'è Valore dell'impresa di Panbela Therapeutics?
Valore dell'impresa di Panbela Therapeutics Inc. è $9.68M
Qual è la definizione di Valore dell'impresa?
Il valore dell'impresa è una misura del valore di mercato totale di un'azienda. È calcolato come capitalizzazione di mercato con debito, interessi di minoranza e azioni privilegiate al netto delle disponibilità liquide e mezzi equivalenti.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valore dell'impresa di aziende nel Health Care settore su NASDAQ rispetto a Panbela Therapeutics
Cosa fa Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Aziende con valore dell'impresa simili a Panbela Therapeutics
- Makers Laboratories ha Valore dell'impresa di $9.66M
- Mohit Industries ha Valore dell'impresa di $9.67M
- Peppermint Innovation ha Valore dell'impresa di $9.67M
- Invigor ha Valore dell'impresa di $9.67M
- Curative Biosciences ha Valore dell'impresa di $9.68M
- Surefire Resources NL ha Valore dell'impresa di $9.68M
- Panbela Therapeutics ha Valore dell'impresa di $9.68M
- Oakdale Resources ha Valore dell'impresa di $9.69M
- Viva Gold ha Valore dell'impresa di $9.69M
- Edensoft ha Valore dell'impresa di $9.69M
- InnovaDerma Plc ha Valore dell'impresa di $9.69M
- General Assembly ha Valore dell'impresa di $9.70M
- Redbank Copper ha Valore dell'impresa di $9.71M